It has been studied that the presence of KRAS p.G12C mutant tumors is correlated with an inflammatory tumor microenvironment and increased immunogenicity, with high PD-L1 expression and better potential sensitivity to ICIs [17,18]. Here, KRAS is linked to neoplasm.